Fig. 1From: Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung diseaseGGO, Case 1. a On day 33 of alectinib therapy, a GGO was detected in the left lower lobe. Alectinib was discontinued. b On day 61, the GGO disappeared after reintroducing alectinib on day 40Back to article page